Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Mineralys Therapeutics Announces Phase 2 Clinical Trial of Lorundrostat for Obstructive Sleep Apnea in Patients with Hypertension
-
Palvella Therapeutics Announces First Patients Dosed in Phase 2 TOIVA Clinical Trial of QTORIN™ 3.9% Rapamycin Anhydrous Gel (QTORIN™ rapamycin) for the Treatment of Cutaneous Venous Malformations
-
Asia Broadband Corporate Update 2025 – Happy New Year
-
Cogent Biosciences Announces Presentation at the 43rd Annual J.P. Morgan Healthcare Conference
-
CytomX Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
-
Corbus Pharmaceuticals Announces that Clinical Data for CRB-701 from Western Dose Escalation Study to be Presented at ASCO GU 2025
-
Windtree Therapeutics Announces New Corporate Strategy Seeking to Identify and Acquire FDA-Approved Revenue Assets While Advancing Its Cardiovascular and Oncology Pipeline
-
COUR Pharmaceuticals Secures FDA Orphan Drug Designation for CNP-104 in Primary Biliary Cholangitis
-
Magna International Inc. Announces Date for Q4 & Year End 2024 Results and 2025 Outlook Webcast
-
Cellebrite Announces Participation in the 27th Annual Needham & Company Growth Conference
-
NV5 Announces New Goal of $1.6 Billion in Revenues by 2028
-
Compass Therapeutics Provides Corporate Update and Announces Advancement of a New Drug Candidate
-
LifeVantage Announces Preliminary Second Quarter Revenue Results and Raises Fiscal 2025 Revenue Guidance
-
Bitterroot Bio Reports Data on Safety and Target Engagement from Phase 1 First-in-Human Study of BRB-002 in Healthy Volunteers
-
ManTech Names Joseph Zuliani Vice President of New Mission Readiness & Enablement Practice
-
Bitdeer Announces December 2024 Production and Operations Update
-
ViGeneron Announces FDA Rare Pediatric Disease Designation for VG901 and DSMB Approval to Advance Dose Escalation in Phase 1b Retinitis Pigmentosa Trial
-
Tokyo Lifestyle Co., Ltd. to Open A New Directly-Operated Store in Hong Kong
-
Infinite Reality Raises $3 Billion; Moves Valuation to $12.25 Billion
-
Denali Therapeutics Announces U.S. FDA Breakthrough Therapy Designation Granted to Tividenofusp Alfa for the Treatment of Hunter Syndrome (MPS II)
-
AXIL Brands Reports Second Quarter Fiscal Year 2025 Financial Results
-
Replimune Announces RP2 Development Program Advances with First Patients Enrolled in Metastatic Uveal Melanoma and Hepatocellular Carcinoma Clinical Trials
-
Sky Quarry Receives Permission to Operate Fractionation Facility at Eagle Springs Refinery Site, Advancing Waste-to-Energy Vision
-
PodcastOne (NASDAQ: PODC) Named 8th Largest US Podcast Publisher by Podtrac for December 2024; Renews Flagship Podcasts with Adam Carolla, Brendan Schaub and Kaitlyn Bristowe
-
UMeWorld Transforms into a Full-Spectrum Wellness Brand with AI-Powered Personalized Solutions
-
Coherus Management to Present at the 43rd Annual J.P. Morgan Healthcare Conference
-
Microbot Medical Announces $8.6 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
-
Acres Debuts Layer Library: Combine and Visualize Land Data Seamlessly
-
authID Receives Industry Luminary Classification in The Prism Project’s 2024 Biometric Digital Identity Flagship Report
-
Gain Therapeutics Announces Formation of Clinical Advisory Board to Support Continued Advancement of Lead Drug Candidate GT-02287
-
Magna International Inc. Announces Date for Q4 & Year End 2024 Results and 2025 Outlook Webcast
-
Bitcoin Depot Expands BTM Network Through Partnership with Prominent Texas Convenience Store Chain
-
Cellebrite Announces Participation in the 27th Annual Needham & Company Growth Conference
-
Kratos Awarded $48 Million Contract for Geolocation Global Support Services
-
STACK Infrastructure Advances Data Center Safety and Releases Breaker Guard Design into Public Domain
-
Tenvie Therapeutics Launches with $200 Million to Deliver Breakthrough Small Molecule Therapies
-
Acronis Appoints Gerald Beuchelt as Chief Information Security Officer
-
DiagnaMed and QIMC to Advance Hydrogen Production Technology at the Ville Marie Clean Natural Renewable Hydrogen Project
-
Cocrystal Pharma Reports Phase 1 Results with Oral, Broad-Acting Antiviral Drug CDI-988 for Prophylaxis and Treatment of Norovirus, Coronaviruses and Other Viral Infections
-
Advanced Ionics Raises $6.7M to Accelerate Technology Commercialization and Deployment
-
Blimburn Seeds Announces USA Expansion
-
Collegium Provides 2025 Financial Guidance and Business Update
-
Protara Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
-
Live Oak Bancshares, Inc. Announces Date of Fourth Quarter 2024 Financial Results
-
New TransUnion Research Reveals Seven in 10 Marketing Leaders Struggle to Connect with Audiences Due to Complex Network of Martech Solutions and Identity Challenges
-
Bonaccord Capital Partners Announces Fund II Final Close at $1.6 Billion
-
Myriad Genetics to Present at 43rd Annual J.P. Morgan Healthcare Conference
-
Horizon Aircraft Announces Exercise of Warrants, Providing an Additional $2.7 Million in Gross Proceeds
-
Indaptus Therapeutics Provides Year-End Review and Outlook for 2025
-
Liquidia Corporation to Present at 43rd Annual J.P. Morgan Healthcare Conference
